Filament Health Corp. Logo

Filament Health Corp.

FLHLF

(0.5)
Stock Price

0,03 USD

-105.05% ROA

-165.67% ROE

-2.42x PER

Market Cap.

12.630.908,24 USD

10.67% DER

0% Yield

-192.34% NPM

Filament Health Corp. Stock Analysis

Filament Health Corp. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Filament Health Corp. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a reasonable amount of debt compared to its ownership (61%), suggesting a balanced financial position and a moderate level of risk.

2 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

3 ROE

The stock's ROE indicates a negative return (-220.09%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-309.17%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (15.05x) suggests it's overvalued, potentially making it an expensive investment.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Filament Health Corp. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Filament Health Corp. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Filament Health Corp. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Filament Health Corp. Revenue
Year Revenue Growth
2020 0
2021 0 0%
2022 364.500 100%
2023 1.349.880 73%
2023 2.130.974 36.65%
2024 438.832 -385.6%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Filament Health Corp. Research and Development Expenses
Year Research and Development Expenses Growth
2020 0
2021 476.602 100%
2022 839.156 43.2%
2023 554.084 -51.45%
2023 793.551 30.18%
2024 619.772 -28.04%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Filament Health Corp. General and Administrative Expenses
Year General and Administrative Expenses Growth
2020 166.591
2021 5.067.241 96.71%
2022 4.009.633 -26.38%
2023 4.061.172 1.27%
2023 5.094.212 20.28%
2024 3.097.352 -64.47%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Filament Health Corp. EBITDA
Year EBITDA Growth
2020 0
2021 -7.078.083 100%
2022 -5.300.255 -33.54%
2023 -4.591.864 -15.43%
2023 -4.710.840 2.53%
2024 -3.381.600 -39.31%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Filament Health Corp. Gross Profit
Year Gross Profit Growth
2020 0
2021 -913.647 100%
2022 364.500 350.66%
2023 1.349.880 73%
2023 1.922.177 29.77%
2024 224.016 -758.05%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Filament Health Corp. Net Profit
Year Net Profit Growth
2020 -191.095
2021 -9.253.607 97.93%
2022 -16.466.465 43.8%
2023 -5.240.276 -214.23%
2023 -5.322.032 1.54%
2024 -4.126.508 -28.97%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Filament Health Corp. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2020 0
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Filament Health Corp. Free Cashflow
Year Free Cashflow Growth
2020 -76.418
2021 -5.537.698 98.62%
2022 -3.898.911 -42.03%
2023 -4.245.276 8.16%
2023 -2.267.944 -87.19%
2024 -499.397 -354.14%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Filament Health Corp. Operating Cashflow
Year Operating Cashflow Growth
2020 -76.418
2021 -5.407.222 98.59%
2022 -3.866.755 -39.84%
2023 -4.187.624 7.66%
2023 -2.230.188 -87.77%
2024 -482.535 -362.18%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Filament Health Corp. Capital Expenditure
Year Capital Expenditure Growth
2020 0
2021 130.476 100%
2022 32.156 -305.76%
2023 57.652 44.22%
2023 37.756 -52.7%
2024 16.862 -123.91%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Filament Health Corp. Equity
Year Equity Growth
2020 813.644
2021 16.552.558 95.08%
2022 3.193.322 -418.35%
2023 2.494.052 -28.04%
2023 2.491.569 -0.1%
2024 3.183.319 21.73%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Filament Health Corp. Assets
Year Assets Growth
2020 881.561
2021 17.842.088 95.06%
2022 4.740.657 -276.36%
2023 5.771.699 17.86%
2023 5.576.109 -3.51%
2024 4.728.116 -17.94%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Filament Health Corp. Liabilities
Year Liabilities Growth
2020 67.917
2021 1.289.530 94.73%
2022 1.547.335 16.66%
2023 3.277.647 52.79%
2023 3.084.540 -6.26%
2024 1.544.797 -99.67%

Filament Health Corp. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.01
Net Income per Share
-0.02
Price to Earning Ratio
-2.42x
Price To Sales Ratio
5.1x
POCF Ratio
-2.25
PFCF Ratio
-2.57
Price to Book Ratio
3.41
EV to Sales
4.7
EV Over EBITDA
-3.07
EV to Operating CashFlow
-2.41
EV to FreeCashFlow
-2.37
Earnings Yield
-0.41
FreeCashFlow Yield
-0.39
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.08
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0.02
Income Quality
1.08
ROE
-1.79
Return On Assets
-1.07
Return On Capital Employed
-1.04
Net Income per EBT
1.01
EBT Per Ebit
1.51
Ebit per Revenue
-1.27
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
1.88
Research & Developement to Revenue
0.35
Stock Based Compensation to Revenue
-0.16
Gross Profit Margin
0.95
Operating Profit Margin
-1.27
Pretax Profit Margin
-1.91
Net Profit Margin
-1.92

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.02
Free CashFlow per Share
-0.02
Capex to Operating CashFlow
-0.02
Capex to Revenue
0.03
Capex to Depreciation
0.37
Return on Invested Capital
-1.19
Return on Tangible Assets
-1.05
Days Sales Outstanding
81.67
Days Payables Outstanding
2677.82
Days of Inventory on Hand
0
Receivables Turnover
4.47
Payables Turnover
0.14
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
0,01
Tangible Book Value per Share
0.01
Shareholders Equity per Share
0.01
Interest Debt per Share
0
Debt to Equity
0.11
Debt to Assets
0.07
Net Debt to EBITDA
0.26
Current Ratio
1.42
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
1831793
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Filament Health Corp. Dividends
Year Dividends Growth

Filament Health Corp. Profile

About Filament Health Corp.

Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.

CEO
Mr. Benjamin Lightburn
Employee
13
Address
2900 – 550 Burrard Street
Vancouver, V6C 0A3

Filament Health Corp. Executives & BODs

Filament Health Corp. Executives & BODs
# Name Age
1 Mr. Steven Nguyen CPA
Interim Chief Financial Officer
70
2 Andry Tjahyana
Vice President of Business Development
70
3 Mr. Jonathan Conlin
Corporate Secretary & Director
70
4 Mr. Ryan Moss
Chief Science Officer
70
5 Mr. Jeff Fellows
Head of Regulatory
70
6 Mr. Benjamin Lightburn
Co-Founder, Chief Executive Officer & Chairman
70
7 Ms. Lisa Ranken
Chief Operating Officer
70
8 Ms. Anna Cordon
Vice President of Marketing & Communications
70
9 Sara Burke B.A., M.B.A.
Head of Global Partnerships
70

Filament Health Corp. Competitors